Industries > Pharma > Oligonucleotide Synthesis Market Forecast 2020-2030

Oligonucleotide Synthesis Market Forecast 2020-2030

Forecasts and Analysis by Product (Probe, Linkers, Adaptor, Drugs, Reagent, Equipment), Type (Custom, Pre Design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Hospital, Pharmaceutical, Biotechnology) and Geography, with Profiles of Leading Companies

PAGES: 171
PRODUCT CODE: PHA0695
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: PHA0695 Categories: , Tag:

According to the report published by Visiongain, the Oligonucleotide Synthesis market is estimated to be valued at approximately USD xx billion in 2019 and is expected to generate around USD xx billion by 2030, at a CAGR of around xx% between 2020 and 2030. Almost every molecular biologic technique used nowadays involves chemical synthesized PCR, Real-Time PCR, site-driven mutagenesis, single-core polymorphism (SNP) tests, microarrays and a rapidly increasing world of small RNAs. Similarly, PCRs are used in almost all molecular biology technologies. Furthermore, in addition to other reagents the oligonucleotide is custom made and cleaned in compliance with the specific needs of the particular researcher, as expected. In the last few years, development has culminated over major performance and production improvements and significant cost savings in the fields of olegonucleotide synthesis, purification and quality control. At the same period, oligonucleotide production has contributed to a drastic rise in the number of modifications usable. The developments in oligonucleotide synthesis, purification and QC have also culminated in the development of high quality products in the wide range of possible syrtheses, such as those found in the integrated DNA technologies, provided that technological advances have led for applications to high performance testing.

The oligonucleotide synthesis demand has increased as a result of increased government spending, research and development expenses on pharmaceutical and biotechnology firms and the use of synthesized oligonucleotides for molecular and medical diagnostics. Thanks to several advantages of molecular diagnostics and increasing medical uses, the use of artificial oligonucleotides has increased rapidly in the last decade. The techniques of nucleic acid application are a benchmark and very useful for molecular diagnosis in various diseases such as hepatitis. for the detection of infectious diseases. Significant medical uses are also available for artificial oligonucleotides, especially for automobile antibodies. Synthetic biology in recent years has been constantly developing, utilizing artificial oligonucleotides to check the identification of anti-double stranded DNAs. Thus the oligonucleotide synthesis sector is accountable for all these reasons.

In addition, the market for oligonucleotide synthesis is also influenced by others. In this context, it is expected to grow in the Oligonuc forecast period, which includes growing advances in the healthcare field, increasing demand for innovation in life sciences and medical academics, increasing government investment in the development of genomic technologies and the increasing demand for oligonucleotide synthesis technologies by public and private probes.

Why you should buy Oligonucleotide Synthesis Market Forecast 2020-2030

Synthesis of oligonucleotides is an important part of several recent experiments in genetics
Decreasing sequencing costs have contributed to increasing demand in science, genetic testing, drug development and forensic applications of custom-made nucleotides for desirable series. In turn, this promoted demand in the various life-science industries for oligonucleotides synthesis. Custom synthesis requests from various classes of oligos including decoies, aptamers and immuno-stimulants, antisense, siRNA and miRNA are projected to increase investment in genetic research. Most big and small suppliers of oligonucleotides grow their market by partnering with drug manufacturers. CordenPharma International, for instance, formed a strategic partnership with GE Healthcare Dharmacon Inc. in June 2017 to establish an end-to-end drug discovery approach for oligonucleotides.

Late clinical trials addressing various conditions, for instance diabetes, heart problems, muscular dystrophies and eye defects are being performed with a substantial number of oligos. This anticipated regulatory approval is expected to promote the market for multiple oligonucleotide based therapies. Direct sales and sales through distributors in specific countries are part of marketings implemented in this market. The market is expected to benefit from constant growth in the genomics and genetic modification markets as progress in genetic instruments simplifies oligonucleotide synthesis.

Introduction of New and Robust Synthesizers
The segment is driven by the introduction of new and robust synthesizers which permit the quick and large-scale production of long oligonucleotide sequences. However, contract-manufacturing and consulting services have increased due to various contract-service provider advantages including improved efficiency, cost-effective services and quick product development. The segment of services is projected to promote growth. A vast array of reagents has contributed significantly to the prevailing proportion of detrityisation / deblocking, corrosion, cleavages, purification / desalting, marking and alteration of oligonucleotides. The segment is also fueled by need for specific reagents at each step of synthesis and high cost.

PCR Primers Have Enjoyed The Highest Share Of Revenue In Oligonucleotide Synthesis
For target testing and detection, PCR primers are commonly used for drug development. In various stages of clinical development, PCR primers have enjoyed the highest share of revenue in oligonucleotide synthesis, thanks to the robust pipelines of oligonucleotide-based therapeutics, including the antidisaster treatment industry, DNA vaccine, and anti-viral agents.

Increasing reliance on selective gene therapies has revolutionized the care for genetically modified incurable diseases. Manufacturers have seen an increase in demand for clinical, diagnostic, academic and pharmaceutical sequencing applications.

Government and Private Entities Are Investing In The Development Of Emerging Economies Academic And Research Infrastructure
The focus is on the research of alternative approaches to treating diseases by the pharmaceutical industry and the biotechnology companies. As a consequence, oligonucleotides are used by these companies as they provide an efficient way of treating different signs at comparatively low development cost. Moreover, the challenge of the efficient way of administration of drugs involves oligonucleotides. This, in turn, will increase oligonucleotide therapy production and increase the share of pharmaceutical and biotechnology firms on the global market.

Government and private entities are investing in the development of emerging economies ‘ academic and research infrastructure. This will increase oligonucleotide adoption in research institutes positive. This factor is expected to be positive. The increase in genomic research projects carried out by academic research institutes has made it possible for this segment to take the dominant market share account. Moreover, the creation of novel approaches to cure of chronic conditions through genetic medicine would contribute to the growth of this segment through the involvement of major players and universities.

Increased market potential permits for pipeline products
In all step clinical studies, the largest proportion of oligonucleotides are used for multiple diseases such as cancer, muscular dystrophy, heart and eye disorders. The growth of the global oligonucleotide synthesis market is expected to result in growing regulatory approvals for multiple therapies especially based on oligonucleotides. Advanced strategy targeting the marketing and adoption including the improvement of direct sales and distributors in particular developing countries. However, oligonucleotide advantages and the success of its synthesis are driving an increase in the global synthesis market for oligonucleotides.

Regional Market Outlook
Innovation and key players in the United States have brought about greater market penetration of products. In 2017, North America was therefore liable for a large portion in sales. In contrast, Northern America has played significantly in sustaining a significant share in gene, proteomics, oncology, medical testing, and drug discovery.

Due to the rapid progress in genomics studies and the healthcare industry, asian countries are the quickest adopters of sequence, spectrum technology and PCR products. As far as expansion or growth opportunities in those countries are concerned, Japan and China are considered the most attractive markets. However, the new economic environment has enabled global players to join the Asia-Pacific market with significant investments in healthcare, life-science programs, and genetics and thus continued to expand them.

What is the future of the Oligonucleotide Synthesis market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.

We guarantee in this 171 page report you will receive the following key information –
• View Oligonucleotide Synthesis market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Oligonucleotide Synthesis revenue forecast
– Oligonucleotide Synthesis connections forecast

• Examine 122 tables, charts, and graphs
– Let our analysts present you with a thorough assessment of the current and future Oligonucleotide Synthesis market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Oligonucleotide Synthesis sector

• Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Oligonucleotide Synthesis industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Oligonucleotide Synthesis submarkets with individual forecasts and analysis from 2020-2030.
– Product submarket forecast 2020-2030
– Type submarket forecast 2020-2030
– Application submarket forecast 2020-2030

• Learn about the market prospects for the leading Oligonucleotide Synthesis market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Oligonucleotide Synthesis revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.

– Product Revenue Forecast 2020-2030
Synthesized Oligonucleotides Market Forecast, 2020-2030
Custom Oligonucleotides Market Forecast, 2020-2030
Pre-designed Oligonucleotides Market Forecast, 2020-2030
Reagents Market Forecast, 2020-2030
Equipment Market Forecast, 2020-2030
Other Product Market Forecast, 2020-2030

– Type Revenue Forecast 2020-2030
Oligonucleotide-based Drugs Market Forecast, 2020-2030
Primers Market Forecast, 2020-2030
Probes Market Forecast, 2020-2030
Large-scale Synthesized Oligonucleotides Market Forecast, 2020-2030
Intermediate-scale Synthesized Oligonucleotides Market Forecast, 2020-2030
Linkers & Adaptors
Other Type Market Forecast, 2020-2030

– Application Revenue Forecast 2020-2030
Research Market Forecast, 2020-2030
PCR Market Forecast, 2020-2030
QPCR Market Forecast, 2020-2030
Sequencing Market Forecast, 2020-2030
Gene Synthesis Market Forecast, 2020-2030
Other Research Applications (nucleic acid hybridization methods and isothermal amplification methods)

Diagnostics Market Forecast, 2020-2030
Therapeutics Market Forecast, 2020-2030
DNA & Antisense Oligonucleotide-based Therapies
RNAi Oligonucleotide-based Therapies
CpG Oligonucleotide-based Therapies
Other Application Market Forecast, 2020-2030

by End User Revenue Forecast 2020-2030
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Hospitals
Other End User Market Forecast,2020-2030

• Understand the prospects for the 4 regional and the leading 12 national Oligonucleotide Synthesis markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Oligonucleotide Synthesis companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts

• Explore the factors affecting Oligonucleotide Synthesis product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry

• Identify who the leading companies are in the Oligonucleotide Synthesis industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Oligonucleotide Synthesis companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.

Leading Companies in the Global Oligonucleotide Synthesis Market
Kaneka Eurogentec S.A.
Biolegio B.V.
Eurofins Scientific SE
Bioneer Corporation
Kaneka Corporation (Eurogentec)
Eton Bioscience, Inc.
Agilent Technologies
Adtbio
Bioautomation (Acquired By LGC)
Bio-Synthesis Inc.
Biogen

With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Oligonucleotide Synthesis Market Forecast 2020-2030: Forecasts and Analysis by Product (Probe, Linkers, Adaptor, Drugs, Reagent, Equipment), Type (Custom, Pre Design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Hospital, Pharmaceutical, Biotechnology) and Geography, with Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Oligonucleotide Synthesis Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Oligonucleotide Synthesis Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Biobanking Market Report 2021-2031

In clinical trials relating to COVID-19, COVID-19 biobanks will play an important role. These biobanks will play an instrumental role in future scientific studies on the emerging coronavirus (COVID-19) pandemic facing the world.

23 October 2020

READ

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

READ

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

READ

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

READ

Categories

Category